ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Aug 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
October 2026
Nuclear Technology
September 2026
Fusion Science and Technology
August 2026
Latest News
Diversification and the common ground
Craig Piercycpiercy@ans.org
Who would have thought, just a few years ago, that we would see so many long-standing barriers to new nuclear development falling like dominoes? Public opinion, policy, regulatory reform, finance and investment, design maturity, nuclear fuel enrichment, and fuel fabrication capacity have all advanced with remarkable speed in the United States.
Conventional wisdom holds that the most effective way to scale up the nuclear supply chain is to do so strategically, matching investments to the needs of reactor developers.
H. Ahmadi, M. Rahgoshay, A. Heydarinasab
Nuclear Science and Engineering | Volume 199 | Number 7 | July 2025 | Pages 1263-1272
Note | doi.org/10.1080/00295639.2024.2440684
Articles are hosted by Taylor and Francis Online.
Positron emission tomography (PET) is an advanced imaging tool for the diagnosis and staging of cancer tumors. This method is based on the detection of increased glycolytic activity in malignant cells, in which cell glucose is concentrated because of an increase in membrane glucose transporters, as well as an increase in some key enzymes, such as hexokinase, which are responsible for glucose phosphorylation. Therefore, for this type of imaging, drugs containing glucose are needed. On the other hand, with the expansion of the use of PET imaging devices, the need for drugs for this type of imaging method [fluorodeoxyglucose drug (FDG)] has also increased significantly. FDG is a drug tracer used in the medical imaging technique of PET. The production of FDG requires the production of 18F and, as a result, reaching 18O with a richness of more than 95%. There are various methods to produce oxygen with high richness. Among these methods, using a distillation column is a suitable method to produce oxygen, which has low efficiency and high production cost. Optimization of the distillation column can reduce the cost of producing high-rich oxygen. Numerical methods are one of the useful techniques for optimization. In this study, the distillation column has been computerized using mathematical models, and then by changing the number of inputs, including the height of the pipes, the temperature of the input of the distillation column has been optimized. Results show that the maximum separation of the desired isotope concentration in the distillation tower depends on the type of isotope desired and the condition of the device and is independent of the type of feed. Also, the input feed has no effect on the concentration distribution.